Long‐term exposure to monoclonal anti‐TNF is associated with an increased risk of lymphoma in BAFF‐transgenic mice

The impact of treatment on the risk of lymphoma in patients with rheumatoid arthritis (RA) is unclear. Here, we aimed to assess if the risk of lymphoma differs according to the type of tumor necrosis factor inhibitor (TNFi), comparing monoclonal anti‐TNF antibodies to the soluble TNF receptor. We us...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Exp Immunol
Hlavní autoři: Nocturne, Gaetane, Ly, Bineta, Paoletti, Audrey, Pascaud, Juliette, Seror, Raphaele, Nicco, Carole, Mackay, Fabienne, Vincent, F.B., Lazure, Thierry, Ferlicot, Sophie, Stimmer, Lev, Pascal, Quentin, Roulland, Sandrine, Krzysiek, Roman, Hacein‐Bey, Salima, Batteux, Frederic, Mariette, Xavier
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2021
Témata:
ORIGINAL ARTICLES
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8274188/
https://ncbi.nlm.nih.gov/pubmed/33864242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13602
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky